Biotech

All Articles

Gene publisher Volume giving up 131 workers

.Only times after gene editor Tome Biosciences introduced hidden operational cuts, a clearer picture...

Repare gives up 25% of team as biotech halts preclinical R&ampD

.Repare Therapeutics is actually laying off a quarter of its workforce as the oncology biotech downs...

J &amp J files for FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken another step toward realizing a return on its own $6.5 billion nipoc...

Gain's period 1 succeed paves way to verify Parkinson's medication's worth

.Gain Rehabs has prepared its direct proving the efficiency of its own Parkinson's illness therapy f...

Actinogen documents new stage 2 data to restore anxiety drug

.Actinogen Medical's hopes-- and sell rate-- have rebounded a little coming from previously this mon...

Pfizer and also Front runner incorporate Ratio to multibillion-dollar equation

.Crown Jewel Pioneering and Pfizer have included Ratio in to their 10-program alliance, inking a bar...

Bayer markers $547M deal to push perimeters of noncoding RNA

.Bayer executives were interested to worry to Tough this summer that the German pharma giant's cravi...

UK introduces plannings to launch 18 brand new medical trial hubs

.Amid a yearslong professional test decline in the U.K., a brand-new public-private alliance has dev...

UPDATE: Genentech telegrams 93 unemployments in California after discussing programs to shutter cancer immunology analysis unit

.Following the news of a huge layoff shot in April and a primary restructuring project unveiled prev...

Neurocrine's KarXT opponent hits in stage 2-- yet only at low dosage

.Neurocrine Biosciences has actually accomplished its hoped-for profile in a phase 2 schizophrenia t...